Bicycle Precision Guided Therapeutics.
Drug Discovery β’ Phage Display β’ Peptide Therapeutics β’ Biotechnology
201 - 500
π° $175M Post-IPO Equity on 2021-10
16 hours ago
201 - 500
Lead medical affairs strategies for Bicycle Therapeutics' oncology assets.
πΊπΈ United States β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π Senior
π Director
π½ H1B Visa Sponsor
Yesterday
201 - 500
Oversee clinical safety operations for Bicycle's drug safety and pharmacovigilance activities.
πΊπΈ United States β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π Senior
βοΈ Operations
π½ H1B Visa Sponsor
4 days ago
201 - 500
Direct global isotope supply chain for Bicycle Therapeutics' innovative medicines.
πΊπΈ United States β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π Senior
π Director
π½ H1B Visa Sponsor
4 days ago
201 - 500
Senior Director for Global Medical Affairs at Bicycle Therapeutics driving medical strategy.
πΊπΈ United States β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π Senior
π Director
π½ H1B Visa Sponsor
4 days ago
201 - 500
Manage Clinical Outsourcing for Bicycle Therapeutics' oncology trials.
πΊπΈ United States β Remote
π° $175M Post-IPO Equity on 2021-10
β³ Contract/Temporary
π‘ Mid-level
π Senior
π Procurement
π½ H1B Visa Sponsor
4 days ago
201 - 500
Lead biostatistical activities for clinical studies at Bicycle Therapeutics.
πΊπΈ United States β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π Senior
π Director
π½ H1B Visa Sponsor
4 days ago
201 - 500
Lead scientific communications strategy for Bicycle Therapeutics' oncology drug development.
πΊπΈ United States β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π Senior
π£οΈ Communications
π½ H1B Visa Sponsor
4 days ago
201 - 500
Manage Quality Assurance for Bicycle's drug development programs.
π¬π§ United Kingdom β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π‘ Mid-level
π Senior
π§ QA Engineer (Quality Assurance)
4 days ago
201 - 500
Lead compliance and ethics for Bicycle Therapeutics, a biopharmaceutical company.
πΊπΈ United States β Remote
π° $175M Post-IPO Equity on 2021-10
β° Full Time
π΄ Lead
π Compliance
π½ H1B Visa Sponsor